Introduction
There has been an increase in the use of non-invasive ventilation (NIV) in the intensive care setting. Guidelines suggest more favourable outcomes when used in patients with chronic obstructive pulmonary disease (COPD) and cardiogenic pulmonary oedema (CPO)[ 1 ], yet its use often extends beyond these indications despite no evidence of clear benefit.
Objectives
To review the practice and outcomes of NIV in our institution over a 1 year period.
Methods
We conducted a retrospective analysis of all patients receiving NIV for the first time at any stage of their ICU admission between 1 st January 2014 and 31 st December 2014. Patients were divided into 3 groups: decompensated respiratory failure (DRF) (pH< 7.35 + pCO2>6KPa pre-NIV), non-decompensated respiratory failure (NDRF) (pH>7.35 or PCO2< 6Kpa pre-NIV) or post extubation. For each patient, the indication and duration of NIV was recorded along with important outcomes that included requirement and duration of mechanical ventilation (MV), length of ICU stay and survival to ICU discharge. NIV following a period of mechanical ventilation was given for 31 patients. In this cohort, NIV was administered for a median duration of 21 hours (range 1-617 hours). 13/31 patients (42%) required re-intubation and further periods of mechanical ventilation.
Royal Free London NHS Foundation Trust, Intensive Care Unit, Barnet Hospital, London, United Kingdom Figure 1 Indications for NIV In our institution, the majority of patients received NIV for indications outside those recommended by guidelines. Those with DRF receiving NIV fared no worse compared with NDRF in this cohort. This along with those receiving NIV following extubation may provide a cohort of patients who warrant further investigation.
